China
Africa
Explore chapters and articles related to this topic
The Role of Exercise in Cancer Therapy
Published in Ronald R. Watson, Marianne Eisinger, Exercise and Disease, 2020
Are there limitations to activity based on pre-existing conditions? — Smoking and high fat intake are risk factors for cardiopulmonary disease shared by many cancer, as well as cardiac, patients. In addition, patients may suffer from such pre-existing conditions as low fitness level, orthopedic injuries, arthritis, and other musculoskeletal disorders. Guidelines developed by the American College of Sports Medicine provide an excellent basis for pre-exercise screening:28 Cancer patients should be screened for exercise clearance as any other population, with particular attention paid to risk factor assessment. Patients with pre-existing cardiac, vascular, or pulmonary disease may benefit from referral to established cardiopulmonary rehabilitation programs for appropriate supervision. Finally, specific contraindications to exercise and exercise testing developed by the American College of Sports Medicine should be adhered to in working with cancer patients.
Cardiovascular Disease
Published in K. Rao Poduri, Geriatric Rehabilitation, 2017
The American Association of Cardiopulmonary Rehabilitation and the AHA have delineated core components that all cardiac rehabilitation programs should provide for secondary prevention efforts.20 The goal of these components is to minimize cardiovascular risks, promote healthy behavior, patient adherence, and promote an active lifestyle for patients with CVD.
The Chaplain/Pastoral Counselor as a Behavioral Medicine Consultant in Cardiac Rehabilitation: A Team Approach
Published in Larry VandeCreek, Laurel Arthur Burton, The Chaplain-Physician Relationship, 2014
Richard D. Underwood, Brenda B. Underwood, Donald Mosley
Finally, the PBMC can serve as a resource to a cardiopulmonary rehabilitation program through individual and family counseling. Integrated training in psychological/spiritual dynamics prepares the PBMC to provide supportive and re-educative counseling to heart/lung patients.
The Arabic version of the Lower Extremity Functional Scale is a reliable and valid measure of activity limitation in people with chronic obstructive pulmonary disease
Published in Disability and Rehabilitation, 2022
Participants in the current study were recruited from the outpatient respiratory clinic at King Saud University Medical City and King Fahad Medical City in Riyadh, Saudi Arabia with ethical approvals obtained from the Ethical Committee in both institutions. Using convenience sampling, participants were recruited if they were at least 35 years of age with a confirmed pulmonologist diagnosis of COPD (post-bronchodilator forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) of less than 0.7) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria [15]. Participants were clinically stable with no exacerbation in the previous two weeks. The study’s exclusion criteria were: (1) inability to read or understand Arabic language; (2) the presence of neurological, musculoskeletal, or cardiovascular disorders perceived by the participants to be the major cause of their activity limitation; (3) the presence of pulmonary disorders other than COPD. Participants signed informed consent form prior to participation. Recruitment and data collection for the current study (December 2019 to February 2020) were completed by two licensed physical therapists specialized in cardiopulmonary rehabilitation.
Influence of Exogenous β-Hydroxybutyrate on Walking Economy and Rating of Perceived Exertion
Published in Journal of Dietary Supplements, 2019
Shaun James, Beau Kjerulf Greer
As little as 2.5–5 hours per week of cardiopulmonary rehabilitation reduces cardiovascular disease (CVD) mortality by 20%–30%, but patients encounter a variety of barriers leading to an attendance rate of 30% and an overall adherence rate of 50% (Sandor et al., 2014). Two of the most frequently reported barriers are exercise intolerance (EI) and/or fatigue (Evenson & Fleury, 2000; Glazer, Emery, Frid, & Banyasz, 2002). These barriers have been consistently associated with impaired quality of life, affecting patients up to five months after participation in a cardiac rehabilitation program (Carmody, Senner, Malinow, & Matarazzo, 1980). Multiple authors have proposed limiting the effects of these barriers through environmental and prescribed exercise interventions, but few to date have explored the potential benefit of metabolic therapy (Glazer et al., 2002; Moore, Dolansky, Ruland, Pashkow, & Blackburn, 2003).
Current challenges in managing comorbid heart failure and COPD
Published in Expert Review of Cardiovascular Therapy, 2018
J. Alberto Neder, Alcides Rocha, Maria Clara N. Alencar, Flavio Arbex, Danilo C. Berton, Mayron F. Oliveira, Priscila A. Sperandio, Luiz E. Nery, Denis E. O’Donnell
Patients with coexisting HF and COPD present a clinical challenge, which defies the current structure of healthcare delivery. These patients should ideally be followed-up by multidisciplinary (e.g. cardiologists, respirologists, specialists in geriatric medicine) and multiprofessional (including specialist nurses, physiotherapists, occupational therapists) healthcare teams devoted to the management of elderly patients with chronic-degenerative diseases: Interpretation of lung function and CPET in HF–COPD needs to take into consideration the respiratory and systemic effects of each disease. CPET in particular remains undervalued and, consequently, underused as a non-invasive tool to uncover the causes of exercise tolerance in combined HF and COPD.Despite the fact that comorbid HF–COPD does not change the foundations of the pharmacological treatment for each disease, the conventional treatment of HF might need to be modified to address its potential effects on COPD-induced symptoms, particularly dyspnea. Conversely, the pharmacological treatment of COPD should be based on a careful balance between symptom control and increased risk of cardiovascular toxicity.In any patient with HF–COPD, physical activity (either in isolation or as a part of combined cardiopulmonary rehabilitation programs) is paramount to decrease symptom burden and improve health-related quality of life.